UNICA IRIS Institutional Research Information System

PAOLETTI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 271.890
NA - Nord America 20.991
AS - Asia 9.144
SA - Sud America 1.416
Continente sconosciuto - Info sul continente non disponibili 483
AF - Africa 197
OC - Oceania 27
Totale 304.148
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 234.295
NL - Olanda 30.582
US - Stati Uniti d'America 20.614
SG - Singapore 3.520
CN - Cina 3.403
UA - Ucraina 2.161
SE - Svezia 1.356
DE - Germania 1.223
BR - Brasile 1.112
FI - Finlandia 762
VN - Vietnam 721
FR - Francia 539
GB - Regno Unito 509
HK - Hong Kong 336
KR - Corea 253
CA - Canada 220
IN - India 195
BD - Bangladesh 184
RU - Federazione Russa 176
AR - Argentina 104
MX - Messico 70
IQ - Iraq 67
JP - Giappone 65
ZA - Sudafrica 52
PK - Pakistan 51
EC - Ecuador 50
PL - Polonia 46
PH - Filippine 45
TR - Turchia 44
ID - Indonesia 38
CO - Colombia 35
EU - Europa 31
VE - Venezuela 31
AT - Austria 30
MA - Marocco 30
ES - Italia 29
BE - Belgio 28
MY - Malesia 26
CL - Cile 25
UZ - Uzbekistan 25
JM - Giamaica 24
SA - Arabia Saudita 23
RO - Romania 22
AU - Australia 21
TN - Tunisia 21
PY - Paraguay 20
KE - Kenya 19
UY - Uruguay 19
IE - Irlanda 18
CH - Svizzera 16
CZ - Repubblica Ceca 16
IL - Israele 16
NP - Nepal 16
EG - Egitto 15
JO - Giordania 15
ET - Etiopia 14
LT - Lituania 13
PE - Perù 13
CR - Costa Rica 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
PT - Portogallo 11
DZ - Algeria 9
GT - Guatemala 9
IR - Iran 9
LB - Libano 9
HN - Honduras 8
KZ - Kazakistan 8
MU - Mauritius 8
SN - Senegal 8
TH - Thailandia 8
BG - Bulgaria 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
MD - Moldavia 7
NO - Norvegia 7
PR - Porto Rico 7
AL - Albania 5
AO - Angola 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
TT - Trinidad e Tobago 5
NI - Nicaragua 4
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
QA - Qatar 4
RS - Serbia 4
SV - El Salvador 4
TW - Taiwan 4
BY - Bielorussia 3
GE - Georgia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NG - Nigeria 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
Totale 303.654
Salva come PNG Salva come JPEG
Città #
Cagliari 227.581
Amsterdam 30.533
Uta 4.957
Singapore 1.723
Fairfield 1.715
Ashburn 1.685
San Jose 1.281
Woodbridge 1.243
Chandler 1.197
Jacksonville 1.167
Boardman 1.064
Dallas 980
Wilmington 890
Ann Arbor 858
Houston 793
Seattle 728
Nyköping 690
Cambridge 569
Beijing 510
Helsinki 430
Dearborn 387
Nanjing 375
Los Angeles 363
Hefei 340
Council Bluffs 327
Hong Kong 306
Lauterbourg 298
Boston 281
Santa Clara 245
Seoul 230
Ho Chi Minh City 229
Buffalo 183
New York 176
The Dalles 164
Milan 161
Hanoi 154
San Diego 119
Shenyang 116
Shanghai 111
Toronto 109
Nanchang 105
Tianjin 100
Guangzhou 96
Changsha 78
Rome 77
Hebei 76
Jiaxing 74
Redwood City 74
São Paulo 71
Chicago 66
Brooklyn 63
Columbus 62
Mountain View 62
London 60
Redondo Beach 60
Verona 60
Orem 58
Jinan 54
Norwalk 53
Washington 53
Frankfurt am Main 51
Orange 51
Tokyo 50
Atlanta 48
Sassari 45
Rio de Janeiro 40
Munich 39
Phoenix 39
San Francisco 39
Warsaw 36
Denver 35
Dong Ket 34
Ningbo 34
Zhengzhou 33
Auburn Hills 32
Da Nang 32
Nuremberg 31
Belo Horizonte 27
Montreal 27
Johannesburg 26
Pune 26
Haiphong 25
Curitiba 24
Tashkent 24
Baghdad 22
Brussels 22
Kunming 22
Las Vegas 22
Campinas 21
Chennai 21
Hải Dương 21
Philadelphia 21
Redmond 21
Stockholm 21
Taizhou 21
Saint Petersburg 20
Hangzhou 19
Manchester 19
Mexico City 19
Kingston 18
Totale 287.848
Salva come PNG Salva come JPEG
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 4.112
Overview of elagolix for the treatment of endometriosis 3.538
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.418
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.409
Systemic therapy for the treatment of endometrial cancer 3.115
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 3.055
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 3.003
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.985
Olfactory performance in relation to sex and hormonal profile in humans 2.932
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.922
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.761
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.746
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.699
Studio epidemiologico sull’osteoporosi postmenopausale 2.595
Vilaprisan for treating uterine fibroids 2.564
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.490
Interference of dopamine infusion on gamma-amino butyric acid (GABA)-stimulated prolactin increase 2.466
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.452
Inhibitory effect of the dopamine agonist bromocriptine on the postcastration gonadotrophin rise in women 2.429
Critical reappraisal of the clinical effectiveness of different methods of assisted fertilization 2.416
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.404
Placental biomarkers 2.364
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.360
Contraception in chronic kidney disease: a best practice position statement by the kidney and pregnancy group of the Italian Society of Nephrology 2.343
Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women 2.316
Radioimmunological determination of apparent free progesterone concentration in plasma samples of pregnant and non-pregnant women 2.302
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.245
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.231
Placental growth factor and preterm delivery 2.164
Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society 2.093
Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women 2.083
Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male-related or unexplained infertility 2.082
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 2.071
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women 2.058
Unbalanced progesterone and estradiol secretion in catamenial epilepsy 2.052
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 2.046
Risultati di uno studio pilota sull’efficacia del palmitoiletanolamide + transpolidatina in donne con endometriosi 2.039
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate 2.035
Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women 2.034
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 2.034
Regulation of body temperature in postmenopausal women: interactions between bromocriptine and the endogenous opioid system 2.030
Maternal perinatal depression, anxiety, fear of birth, and perception of infants’ negative affectivity at three months 1.998
Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women 1.995
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.940
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.923
Il bi-test: solo screening di cromosomopatie fetali? 1.908
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.906
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.903
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.895
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 1.834
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 1.828
Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study 1.817
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.777
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.768
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.767
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.752
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study 1.751
Successful laparoscopic management of a giant ovarian cyst 1.730
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.714
Changes in GABAA receptor gamma2 subunit gene expression induced by long-term administration of oral contraceptives in rats 1.690
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group 1.670
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.610
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.599
Contraception with estradiol valerate and dienogest: adherence to the method 1.597
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.584
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.566
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.546
Gamma-amino-beta-hydroxy butyric acid stimulates prolactin and growth hormone release in normal women 1.540
Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study 1.513
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.499
LE ALTERAZIONI DELLA FASE OVULATORIA 1.467
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update 1.455
XO/XY mosaicism with non fluorescent Y chromosome: clinical, cytogenetic and endocrinological studies on a female subject 1.440
Soy isoflavones, inulin, calcium, and vitamin D3 in post-menopausal hot flushes: an observational study 1.424
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 1.421
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.401
Placental growth factor and placental perfusion 1.399
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.395
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.393
Relevant changes in nephrogenesis in Down syndrome 1.385
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women 1.375
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.370
Left : right side ratio of endometriotic implants in the pelvis 1.364
Apparent free cortisol concentration in normal men, non-pregnant, pregnant and postmenopausal women 1.327
The screening of tubal abnormalities in the infertile couple 1.314
Pattern of bone markers during pregnancy and their changes after delivery. 1.312
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.309
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.306
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women 1.293
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.288
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.264
EZIOPATOGENESI DEI MIOMI UTERINI 1.249
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.229
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.208
The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study 1.203
Correlazioni tra composizione corporea ed età 1.187
The treatment of polycystic ovary syndrome 1.185
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 1.146
The 12-month treatment with the oral contraceptive formulation containing dienogest (DNG) and estradiol valerate (E2V) shows beneficial effects on psychological symptoms: results from a prospective comparative study with a formulation containing ethinyl estradiol (EE) and drospirenone (DRSP) 1.103
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? 1.101
Totale 193.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 430.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 430.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212.380 0 1.099 581 1.097 1.273 1.049 1.223 678 1.119 1.172 1.516 1.573
2022/202319.530 2.034 2.185 2.190 1.436 1.536 1.748 773 3.042 1.287 981 1.548 770
2023/202425.933 1.565 1.429 1.192 1.953 2.807 4.246 4.430 1.463 1.198 1.745 2.055 1.850
2024/202541.293 4.382 6.941 5.441 4.813 2.487 4.475 3.433 302 709 6.868 561 881
2025/202639.523 795 924 2.066 1.451 922 1.163 2.292 690 25.404 1.884 1.533 399
2026/20271.569 925 644 0 0 0 0 0 0 0 0 0 0
Totale 304.148